hVIVO (LSE:HVO) Other Current Liabilities : £31.39 Mil (As of Dec. 2023)

View and export this data going back to 2012. Start your Free Trial

What is hVIVO Other Current Liabilities?

hVIVO's other current liabilities for the quarter that ended in Dec. 2023 was £31.39 Mil.

hVIVO's quarterly other current liabilities increased from Dec. 2022 (£24.78 Mil) to Jun. 2023 (£25.03 Mil) and increased from Jun. 2023 (£25.03 Mil) to Dec. 2023 (£31.39 Mil).

hVIVO's annual other current liabilities increased from Dec. 2021 (£15.06 Mil) to Dec. 2022 (£24.78 Mil) and increased from Dec. 2022 (£24.78 Mil) to Dec. 2023 (£31.39 Mil).

hVIVO Other Current Liabilities Historical Data

The historical data trend for hVIVO's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

hVIVO Other Current Liabilities Chart

hVIVO Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Current Liabilities

Get a 7-Day Free Trial

hVIVO Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Other Current Liabilities	Get a 7-Day Free Trial															-	-	-	-	-

hVIVO Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

hVIVO Other Current Liabilities Related Terms

Thank you for viewing the detailed overview of hVIVO's Other Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

hVIVO (LSE:HVO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » hVIVO PLC (LSE:HVO) » Definitions » Other Current Liabilities

Comparable Companies

Traded in Other Exchanges

OPORF:USA HVO:Ireland ORPH:UK CRO:Germany

Address

42, New Road, Queen Mary Bioenterprises Innovation Centre, London, GBR, E1 2AX

Website

https://www.hvivo.com

hVIVO PLC is a European-focused, rare, and orphan drug consulting services platform. The principal activity of the Group is that of a rapidly growing specialist CRO pharmaceutical services company, which involves the testing of vaccines and antivirals using human-challenge clinical trials. The group is also engaged in Venn Life Sciences' Clinical Research Division, providing a suite of consulting and clinical trial services to pharmaceutical, biotechnology, and medical device organizations.

hVIVO (LSE:HVO) Headlines

No Headlines